December 17, 2013

Helix BioPharma Announces Director Resignation (PDF)

AURORA, ON–(Marketwired – Dec 17, 2013) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced that Mario Gobbo has resigned from Helix’s board of directors.